This inventor holds 4 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ulm, DE (2020)
- Ulm-Einsingen, DE (2017 - 2023)
Company Filing History:
Years Active: 2017-2023
Title: The Innovations of Peter Schneider
Introduction
Peter Schneider is a notable inventor based in Ulm-Einsingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. With a total of four patents to his name, Schneider's work has the potential to impact the treatment of various diseases.
Latest Patents
Schneider's latest patents focus on pharmaceutical compositions that include fixed dose combinations of DPP-4 inhibitors and SGLT-2 inhibitors alongside metformin XR. These inventions aim to provide effective treatment options for specific medical conditions. Another patent involves pharmaceutical compositions that combine SGLT-2 inhibitors with partner drugs, detailing processes for their preparation and methods for treating diseases.
Career Highlights
Peter Schneider is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has allowed him to explore and develop innovative solutions in the pharmaceutical industry. Schneider's expertise and dedication to research have positioned him as a key figure in his field.
Collaborations
Throughout his career, Schneider has collaborated with esteemed colleagues such as Masanori Ito and Kenji Egusa. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical innovations.
Conclusion
Peter Schneider's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of teamwork in achieving significant breakthroughs in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile